Cellular and Molecular Signaling as Targets for Cancer Vaccine Therapeutics

Area of Science:

• Immunology
• Pharmacology
• Oncology

Background:

• Inflammatory processes are strongly associated with the development of chronic diseases, including various cancers.
• Current immune-modulatory therapeutics, such as PD-1/PD-L1 inhibitors, face limitations in cost and efficacy, highlighting the need for novel approaches.

Purpose of the Study:

• To investigate the potential of medicinal herbs and derived phytochemical compounds in modulating immune responses for cancer treatment.
• To elucidate key cellular and molecular immune-signaling mechanisms relevant to inflammation-driven cancers.

Main Methods:

• Focused research on selected medicinal herbs and purified phytochemical compounds.
• In-depth study of specific immune-signaling pathways at cellular and molecular levels.

Main Results:

• Generated significant research findings on the immune-modulatory effects of phytochemicals.
• Identified key mechanisms underlying inflammation-related cancer development.

Conclusions:

• The study's findings provide a foundation for developing novel phytochemical-based drugs against cancer.
• Highlights the potential of targeting immune-regulatory mechanisms for more effective and accessible cancer therapies.